Key result
Elevated glomerular BAFF expression correlates with inflammatory infiltrates predominantly in class IV lupus nephritis.
Observational (n=52)
Answers are grounded in this paper and cite their sources.
Prospective descriptive study demonstrates class-specific BAFF and receptor expression in lupus nephritis biopsies, highlighting potential utility for guiding targeted anti-BAFF therapies.
Background/Objective B-cell activating factor (BAFF) plays an important role in the pathogenesis of systemic lupus erythematosus. However, the role of BAFF in lupus nephritis (LN) is not understood. Our aim was to evaluate the expression of BAFF and its three receptors in renal biopsy samples from patients with LN and investigate a relationship with pathological class. Methods We conducted a prospective descriptive study (2011-2014) on 52 kidney biopsy samples from patients with LN. Immunohistochemistry for BAFF, its receptors (transmembrane activator and calcium modulator and cyclophilin ligand interaction (TACI), protein maturation of B cells (BCMA), and BAFF-receptor (BAFF-R)), and CD20 expression was performed. Samples were scored according to the percentage of cells with positive expression. Results In class II LN, BAFF-R and TACI were not expressed, whereas BCMA and BAFF were lowly expressed in the interstitial inflammatory infiltrates. Proliferative class III/IV had elevated BAFF expression in the glomeruli, and TACI was expressed in interstitial inflammatory infiltrates and the glomeruli. Interestingly, the class IV cases with vasculopathy ( n = 4) had endothelial BAFF expression, which was not visible in thrombotic microangiopathy ( n = 4). Class V was characterized by low BAFF expression in interstitial inflammatory infiltrates and by BAFF, TACI, and BCMA expression in the glomeruli. BAFF expression was associated with inflammatory scores and CD20 positive infiltrates, mainly in class IV. Conclusions Expression patterns of BAFF and its receptors differ according to LN class. Our study provides evidence that BAFF could be used as a routine marker in LN biopsies and to determine which patients will benefit from anti-BAFF therapy.
No takes yet. Share an insight, caveat, or question.
Suso et al. (2017) conducted an observational in Lupus nephritis (n=52). Renal expression of BAFF and its receptors (TACI, BCMA, BAFF-R) vs. Different lupus nephritis pathological classes (classes II, III/IV, and V) was evaluated on Percentage of cells with positive immunohistochemistry expression of BAFF, TACI, BCMA, BAFF-R, and CD20 across lupus nephritis pathological classes. BAFF and receptor expression in 52 lupus nephritis biopsies varied by pathological class, with elevated glomerular BAFF and inflammatory infiltrate associations mainly in class IV.
Synapse has enriched 10 related papers. Consider them for comparative context: